These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 1496432)
41. [Certain features of the clinical picture and pathomorphology of Parkinson disease of different etiology]. Martynov IuS; Zenkevich GS; Tochilovskiĭ AS Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(7):1033-9. PubMed ID: 7415721 [TBL] [Abstract][Full Text] [Related]
42. MPTP toxicity: clinical features. Williams A J Neural Transm Suppl; 1986; 20():5-9. PubMed ID: 3489070 [TBL] [Abstract][Full Text] [Related]
43. Drugs inducing or aggravating parkinsonism: a review. Marti-Massó JF; Poza JJ; Lopez de Munain A Therapie; 1996; 51(5):568-77. PubMed ID: 9138399 [TBL] [Abstract][Full Text] [Related]
46. Nongenetic causes of Parkinson's disease. Chade AR; Kasten M; Tanner CM J Neural Transm Suppl; 2006; (70):147-51. PubMed ID: 17017522 [TBL] [Abstract][Full Text] [Related]
47. [Parkinson's disease due to laboral exposition to paraquat]. León-Verastegui AG Rev Med Inst Mex Seguro Soc; 2012; 50(6):665-72. PubMed ID: 23331754 [TBL] [Abstract][Full Text] [Related]
48. Parkinsonism following neuroleptic exposure: A double-hit hypothesis? Erro R; Bhatia KP; Tinazzi M Mov Disord; 2015 May; 30(6):780-5. PubMed ID: 25801826 [TBL] [Abstract][Full Text] [Related]
49. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Wang JD; Huang CC; Hwang YH; Chiang JR; Lin JM; Chen JS Br J Ind Med; 1989 Dec; 46(12):856-9. PubMed ID: 2611159 [TBL] [Abstract][Full Text] [Related]
50. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure. Hageman G; van der Hoek J; van Hout M; van der Laan G; Steur EJ; de Bruin W; Herholz K J Neurol; 1999 Mar; 246(3):198-206. PubMed ID: 10323318 [TBL] [Abstract][Full Text] [Related]
51. Parkinsonism due to n-hexane exposure. Pezzoli G; Barbieri S; Ferrante C; Zecchinelli A; Foà V Lancet; 1989 Oct; 2(8667):874. PubMed ID: 2571809 [No Abstract] [Full Text] [Related]
52. Manganese as possible ecoetiologic factor in Parkinson's disease. Feldman RG Ann N Y Acad Sci; 1992 May; 648():266-7. PubMed ID: 1637054 [No Abstract] [Full Text] [Related]
53. Lessons from the rotenone model of Parkinson's disease. Greenamyre JT; Cannon JR; Drolet R; Mastroberardino PG Trends Pharmacol Sci; 2010 Apr; 31(4):141-2; author reply 142-3. PubMed ID: 20096940 [No Abstract] [Full Text] [Related]
54. [Presenile dementia as an occupational diseases following exposure to organic solvents. A review of literature]. Mikkelsen S; Gregersen P; Klausen H; Døssing M; Nielsen H Ugeskr Laeger; 1978 Jul; 140(27):1633-8. PubMed ID: 684908 [No Abstract] [Full Text] [Related]
55. Manganese and Parkinson's disease: a critical review and new findings. Guilarte TR Environ Health Perspect; 2010 Aug; 118(8):1071-80. PubMed ID: 20403794 [TBL] [Abstract][Full Text] [Related]
56. [Parkinsonism due to manganese intoxication]. Juncos RA; Abdala J; Celis DO Rev Fac Cienc Med Cordoba; 1968; 26(1):57-63. PubMed ID: 5731925 [No Abstract] [Full Text] [Related]